Associated Papers
Effects of RARα ligand binding domain mutations on breast fibroepithelial tumor function and signaling.
Huang XX et al.
Npj Breast Cancer, 2025
De novo variants implicate chromatin modification, transcriptional regulation, and retinoic acid signaling in syndromic craniosynostosis.
Timberlake AT et al.
American Journal of Human Genetics, 2023
Analysis on GENIE reveals novel recurrent variants that affect molecular diagnosis of sizable number of cancer patients.
Koyama T et al.
Bmc Cancer, 2019
30709382 (PubMed )
Supplement: 12885_2019_5313_MOESM3_ESM.xlsx › supplementary_3_filtered
Genomic analysis of 220 CTCLs identifies a novel recurrent gain-of-function alteration in RLTPR (p.Q575E).
Park J et al.
Blood, 2017
Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia.
Madan V et al.
Leukemia, 2016
27063598 (PubMed )
Supplement: leu201669x7.xls › Sheet_1
Genomic landscapes of breast fibroepithelial tumors.
Tan J et al.
Nature Genetics, 2015
Frequent mutations in the ligand-binding domain of PML-RARalpha after multiple relapses of acute promyelocytic leukemia: analysis for functional relationship to response to all-trans retinoic acid and histone deacetylase inhibitors in vitro and in vivo.
Zhou DC et al.
Blood, 2002
Select a paper to view details